Variable | OR (95% CI) | P value |
---|---|---|
COVID-19 positive | 0.04 (0.01, 0.16) | < 0.001 |
Sex | 1.27 (0.51, 3.17) | 0.605 |
Age | 1.03 (1, 1.06) | 0.09 |
Affected ear | Â | Â |
 Left | Reference |  |
 Right | 1.99 (0.62, 6.43) | 0.248 |
 Bilateral | 2.32 (0.66, 8.13) | 0.188 |
Duration of aural symptoms | 1.02 (1.01, 1.03) | 0.001 |
History of OME | 3.53 (1.36, 9.11) | 0.009 |
History of tympanocentesis | 4.05 (1.51, 10.88) | 0.006 |
History of VTI | 7.6 (2.2, 26.28) | 0.001 |
HT | 1.27 (0.37, 4.43) | 0.705 |
DM | 0.66 (0.07, 5.95) | 0.712 |
Tumors | 0.3 (0.06, 1.38) | 0.121 |
Intranasal steroid | 1.31 (0.5, 3.41) | 0.585 |
Nasal decongestant | 0.44 (0.17, 1.15) | 0.093 |
Mucolytics | 1.38 (0.53, 3.58) | 0.514 |
Oral antibiotics | 0.48 (0.1, 2.27) | 0.352 |
Tympanocentesis | 2.38 (0.92, 6.18) | 0.075 |